A. Albittar

Immunotherapy for Melanoma.

I. G. Glitza Oliva, O. Alhalabi, I. Oliva, 2020, Advances in experimental medicine and biology.

Pneumonitis after immune checkpoint inhibitor therapies in patients with acute myeloid leukemia: A retrospective cohort study

T. Mendoza, M. Konopleva, S. Faiz, 2022, Cancer.

Cardiac toxicities of anticancer treatments: chemotherapy, targeted therapy and immunotherapy.

Peter Y. Kim, J. Durand, J. Lopez-Mattei, 2019, Current opinion in cardiology.

Studying medicine in crisis: Students' perspectives from Syria

A. Albittar, Tarek Turk, O. A. Aboshady, 2016, Medical teacher.

Transplantation for myeloid neoplasms with antecedent solid tumor

H. Deeg, A. Albittar, A. J. Portuguese, 2022, Cancer.

Outcomes of changing systemic therapy in patients with relapsed breast cancer and 1 to 3 brain metastases

V. Valero, N. Ibrahim, D. Tripathy, 2021, NPJ breast cancer.

Supportive care for the prevention of nausea, vomiting and anorexia in a phase 1B study of selinexor in advanced cancer patients: an exploratory study

F. Meric-Bernstam, A. Naing, S. Piha-Paul, 2021, Investigational New Drugs.

Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience

T. Mendoza, S. Faiz, M. Godoy, 2023, The oncologist.

Immunotherapy for Melanoma.

I. G. Glitza Oliva, O. Alhalabi, A. Albittar, 2020, Advances in experimental medicine and biology.